Director of Office of the CEO, Founder in Residence

Menlo Park, CA. Posted 4 months ago

The role

You will lead high-priority strategic and operational projects for the CEO and Chief of Staff. This 12 to 18 month program involves working on product launches, commercial strategy, and business incubation before graduating into a permanent senior operating role.

What you will do

Lead high-priority strategic and operational initiatives sourced from the CEO.
Identify and fix under-performing processes, workflows, or functions.
Lead and influence cross-functional teams across various departments.
Use AI-native fluency to drive results in ambiguous environments.
Participate in CEO meetings and present to the executive team.
Serve as a thought partner to the CEO and Chief of Staff.

Required qualifications

6-10+ years of building or operating experience
Background as a founder of a company that was acquired, wound down, or moved on from, OR a senior executive (COO, CPO, VP-level) who joined a top scaleup as one of its first 5 to 10 employees, OR a to
First-principles thinker with exceptional analytical horsepower
Builder mentality
AI-native fluency in using AI tools
Strong written and verbal communication
Genuine interest in molecular diagnostics and the BillionToOne mission
Relocation to SF Bay Area required

Nice to have

Prior exposure to healthcare, life sciences, molecular diagnostics, or other regulated industries
Track record of building 0 to 1
Existing network in the founder community, YC ecosystem, or top scaleup operating community

Benefits

Multiple medical benefit options
Employee premiums paid 100% of select plans
Dependents covered up to 80%
16 weeks paid Family Bonding Leave for eligible employees
Supplemental fertility benefits coverage
Retirement savings program including a 4% Company match
Increase paid time off with increased tenure
Latest and greatest hardware
Free daily on-site lunches
State of the art gym and restaurant on campus
Free on-site EV charging

About the company

BillionToOne is a next-generation molecular diagnostics company on a mission to make powerful, accurate diagnostic tests accessible to everyone. It is a publicly traded company on Nasdaq.